{"title": "Astragalus health benefits, dosage, safety, side effects, and supporting evidence. | Supplements | Examine", "author": "Thomas Solomon; Examine com", "url": "https://examine.com/supplements/astragalus/", "hostname": "examine.com", "description": "The latest and most important research on Astragalus. Expert analysis on practical effects, potential risks, and more.", "sitename": "Examine", "date": "2023-07-22", "cleaned_text": "Chinese medicine](/other/traditional-chinese-medicine/). It is claimed to have anti-inflammatory, cardioprotective, and anti-aging effects. Astragalus is most often used for Various Astragalus species are used in alternative medicine around the world. [[1]](/supplements/astragalus/#ref-1) [[2]](/supplements/astragalus/#ref-2) This page refers to Astragalus membranaceus, a popular herb used in [traditional Chinese [[4]](/supplements/astragalus/#ref-4) Astragalus membranaceus can be used alone, but it is also paired with another herb called Angelicae sinensis in Danggui Buxue Tang, a Chinese bioactive compounds, including polysaccharides, [flavonoids](/foods/flavonoids/), and saponins. One of its major bioactive molecules is called astragaloside IV. [[6]](/supplements/astragalus/#ref-6) [[7]](/supplements/astragalus/#ref-7), and another of its bioactive extracts has been patented under the name TA-65 (telomerase activator 65). [[8]](/supplements/astragalus/#ref-8) There are widespread claims about the beneficial effects of Astragalus membranaceus and its extracts (e.g., astragaloside IV, TA-65, etc.) on several conditions. These include chronic heart failure, [[9]](/supplements/astragalus/#ref-9) [[10]](/supplements/astragalus/#ref-10) [[22]](/supplements/astragalus/#ref-22) [[23]](/supplements/astragalus/#ref-23) [[24]](/supplements/astragalus/#ref-24) [[25]](/supplements/astragalus/#ref-25) However, the quality of evidence for these effects in humans is generally low because of variable findings between studies, poor methodological quality, unclear methodological details, widespread lack of blinding, use of intravenous rather than oral administration, and [publication bias](https://catalogofbias.org/biases/publication-bias/) in favor of predominantly positive the evidence supporting the benefits of astragaloside IV is derived from animal and cell culture experiments, [[26]](/supplements/astragalus/#ref-26) [[15]](/supplements/astragalus/#ref-15) [[16]](/supplements/astragalus/#ref-16) [[27]](/supplements/astragalus/#ref-27) [[21]](/supplements/astragalus/#ref-21) [[28]](/supplements/astragalus/#ref-28) while clinical studies showing the therapeutic benefit of TA-65 are authored by the group that patented the compound. [[8]](/supplements/astragalus/#ref-8) [[11]](/supplements/astragalus/#ref-11) Consequently, high-quality randomized controlled clinical trials by independent researchers are urgently needed to confirm these therapeutic claims. There is no obvious toxicity nor serious side effects caused by Astragalus membranaceus [[10]](/supplements/astragalus/#ref-10) However, human studies effects of astragalus. [[17]](/supplements/astragalus/#ref-17) [[33]](/supplements/astragalus/#ref-33) [[32]](/supplements/astragalus/#ref-32) [[9]](/supplements/astragalus/#ref-9) [[10]](/supplements/astragalus/#ref-10) [[20]](/supplements/astragalus/#ref-20) The main drawback is that research in this field has major limitations. For example, systematic reviews conclude that evidence in this field is generally of low unclear which species (e.g., Astragalus membranaceus) or part (entire plant, roots, flowers, etc.) of an Astragalus plant is used, or which type of extract is administered (i.e., a total or purified extract). Additionally, astragalus extracts are often combined with other compounds or drugs so their direct effects cannot always be determined. These limitations reduce the certainty of the claimed benefits. Pharmacological research indicates that Astragalus membranaceus [[3]](/supplements/astragalus/#ref-3) and immunological systems, as well as increase telomerase activity, which prolongs the lifespan of cells. This may explain the potential role of astragalus in the treatment of chronic disease. However, most pharmacological evidence is derived from cell culture (i.e., in vitro) and animal experiments. [[26]](/supplements/astragalus/#ref-26) [[15]](/supplements/astragalus/#ref-15) [[16]](/supplements/astragalus/#ref-16) [[27]](/supplements/astragalus/#ref-27) [[21]](/supplements/astragalus/#ref-21) [[28]](/supplements/astragalus/#ref-28) Further clinical pharmacology research is needed to fully understand the potential mechanism(s) of action in humans. - Astragalus - huangqi - (A Component Of) Danggui Buxue Tang (DBT) - Membranous Milk-vetch Root - Astragalus Sinensis are highly synergistic, meaning they are more powerful when taken together. This combination is traditionally called Dang-gui buxue tang. The starting point for the preparation of Dang-gui buxue tang in traditional Chinese medicine is 30g membranaceus root paired with 6g of Angelicae sinensis. This is a 5:1 ratio, which is ideal for extracting the bioactive ingredients of the plants. Astragalus membranaceus can also be supplemented via a root extract. Due to potential differences in the quality/efficiency of the extraction process among different commercial manufacturers, product label recommendations for dosage should be followed and you should consult with your pharmacist or personal physician before taking. The main bioactive compound in Astragalus membranaceus is astragaloside IV, which can be supplemented by itself. The standard dose for astragaloside IV is 5-10mg. Unlock the full potential of Examine [Get started](/plus/) [^](#ref-link-1)Amiri MS, Joharchi MR, M, Sadaka C [Astragalus its chemical composition toward pharmacological applications.](https://pubmed.ncbi.nlm.nih.gov/33325585)Phytother Res.(2020-Dec-16) [^](#ref-link-3)Liu P, Zhao H, Luo (Huangqi): A Well-Known Chinese Tonic.](https://pubmed.ncbi.nlm.nih.gov/29344421)Aging Dis.(2017-Dec) [^](#ref-link-4)Fu J, Wang Z, Huang L, Zheng S, Wang D, Chen S, Zhang H, Yang S [Review of the botanical characteristics, Wu C, Gao L, Du G, Qin X [Astragaloside IV derived from Astragalus membranaceus: A research review on the pharmacological effects.](https://pubmed.ncbi.nlm.nih.gov/32089240)Adv Pharmacol.(2020) [^](#ref-link-7)Gu Y, Wang G, Pan G, Fawcett JP, A J, Sun J [Transport and bioavailability studies of astragaloside IV, LA, Raffaele JM [A natural product telomerase part of health maintenance program.](https://pubmed.ncbi.nlm.nih.gov/20822369)Rejuvenation Res.(2011-Feb) [^](#ref-link-9)Fu S, Zhang J, Menniti-Ippolito F, Gao X, Galeotti F, Massari M, Hu L, Zhang B, Ferrelli R, Fauci A, Firenzuoli F, Shang H, Guerra R, Raschetti R [Huangqi injection (a traditional Chinese patent medicine) for chronic heart failure: a systematic review.](https://pubmed.ncbi.nlm.nih.gov/21573109)PLoS One.(2011-May-06) [^](#ref-link-10)Wang K, Wu J, Duan X, Wu J, Zhang D, Zhang X, Zhang B [Huangqi injection in the treatment of chronic heart failure: A systematic review and meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/28953668)Medicine (Baltimore).(2017-Sep) [^](#ref-link-11)Fernandez ML, Thomas MS, Lemos BS, DiMarco Melough M, Chun HM, Medina-Vera I [TA-65, A Telomerase with Metabolic Syndrome.](https://pubmed.ncbi.nlm.nih.gov/29546832)Curr Pharm Des.(2018) [^](#ref-link-12)Yu L, Zhou C, Luo Z, Zeng W, Lai F, Han G, Song Y [The lipid-lowering effects of Danhong and Huangqi clinical controlled trials.](https://pubmed.ncbi.nlm.nih.gov/29747663)Lipids Health Dis.(2018-May-10) [^](#ref-link-13)Tian H, Lu J, He H, Zhang L, Dong Y, Yao H, Feng W, Wang S [The effect of Astragalus as an adjuvant treatment in type 2 diabetes mellitus: A (preliminary) meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/27269392)J Ethnopharmacol.(2016-Sep-15) [^](#ref-link-14)Zhang K, Pugliese M, Pugliese A, Passantino active ingredients of traditional Chinese herb Astragalus membranaceus on treatment of diabetes: a systematic review.](https://pubmed.ncbi.nlm.nih.gov/25723453)Mini Rev Med Chem.(2015) [^](#ref-link-15)Zhou XT, Zou JJ, Ao C, Gong DY, Chen X, Ma YR [Renal protective effects of astragaloside IV, in diabetes mellitus kidney damage animal models: A systematic review, meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/32942018)Pharmacol Res.(2020-Oct) [^](#ref-link-16)Wang H, Zhuang Z, Huang YY, Zhuang ZZ, Jin Y, Ye HY, Lin XJ, Zheng Q, Wang YL [Protective Effect and Possible Mechanisms of Astragaloside IV in Animal Models of Diabetic Nephropathy: A Preclinical Systematic Review and Meta-Analysis.](https://pubmed.ncbi.nlm.nih.gov/32695006)Front Pharmacol.(2020) [^](#ref-link-17)Hong Wei Zhang, Zhi Xiu Lin, Chuanshan Xu, Connie Leung, Lai Sum Chan [Astragalus (a traditional Chinese medicine) for treating chronic kidney disease](https://pubmed.ncbi.nlm.nih.gov/25335553)Cochrane Database Syst Rev.(2014 Oct 22) [^](#ref-link-18)Feng M, Yuan W, Zhang R, Fu P, Wu T [Chinese herbal medicine Huangqi type formulations Rev.(2013-Jun-05) [^](#ref-link-19)Zhang L, Shergis JL, Yang L, Zhang AL, Guo X, Zhang L, Zhou S, Zeng L, Mao W, Xue CC [Astragalus membranaceus (Huang Qi) as adjunctive therapy for diabetic kidney disease: An updated systematic review and meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/31034954)J Ethnopharmacol.(2019-Jul-15) [^](#ref-link-20)ZhongChi Xu, LiChao Qian, RuGe Niu, Ying Yang, ChunLing Liu, Xin Lin [Efficacy of Huangqi Injection in the Treatment of Hypertensive Nephropathy: A Systematic Review and Meta-Analysis](https://pubmed.ncbi.nlm.nih.gov/35547210)Front Med (Lausanne).(2022 Apr 25) [^](#ref-link-21)Ianara M Costa, Francisca O V Lima, Luciana C B Bianca Norrara, Francisca I [Astragaloside IV Supplementation Promotes A Neuroprotective Effect in Experimental Models of Neurological Disorders: A Systematic Review](https://pubmed.ncbi.nlm.nih.gov/30207235)Curr Neuropharmacol.(2019) [^](#ref-link-22)Cheng M, Hu J, Zhao Y, Jiang J, Qi R, Chen S, Li Y, Zheng H, Liu R, Guo Q, Zhang X, Qin Y, Hua B [Efficacy and Safety of -Containing Traditional Chinese Medicine Combined With Platinum-Based Chemotherapy in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis.](https://pubmed.ncbi.nlm.nih.gov/34422628)Front Oncol.(2021) [^](#ref-link-23)Shen Cui ZY, Joo JC, Park SJ [Astragalus-Containing Chinese Herbal Medicine Combined With Chemotherapy for Cervical Cancer: A Systematic Review and Meta-Analysis.](https://pubmed.ncbi.nlm.nih.gov/34393766)Front Pharmacol.(2021) [^](#ref-link-24)Lin S, An X, Guo Y, Gu J, Xie T, Wu Q, Sui X [Meta-Analysis of Astragalus-Containing Traditional Chinese Medicine Combined With Chemotherapy for Colorectal Cancer: Efficacy and Safety to Tumor Response.](https://pubmed.ncbi.nlm.nih.gov/31456940)Front Oncol.(2019) [^](#ref-link-25)Cao A, He H, Wang Q, Li L, An Y, Zhou X [Evidence of Astragalus injection combined platinum-based chemotherapy in advanced nonsmall cell lung cancer patients: A systematic review and meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/30882655)Medicine (Baltimore).(2019-Mar) [^](#ref-link-26)Han Z, Zhu J, Han Z hepatic GQ, Wang Y [Astragaloside IV Exerts Cardioprotection in Animal Models of Viral Myocarditis: A Preclinical Systematic Review and Meta-Analysis.](https://pubmed.ncbi.nlm.nih.gov/31849654)Front Pharmacol.(2019) [^](#ref-link-28)Zheng Q, Zhu JZ, Bao XY, Zhu PC, Q, Huang YY, Zhang QH, Zhang KJ, Zheng GQ, Wang Y [A Preclinical Systematic IV for Myocardial Ischemia/Reperfusion Chang GT, Kim H [Safety evaluation of Astragalus extract mixture HT042 its E, Szakonyin\u00e9 IP [Toxicological Evaluation a Mixture of and Root Extracts (InnoSlim\u00ae).](https://pubmed.ncbi.nlm.nih.gov/31354815)J Toxicol.(2019) [^](#ref-link-31)Harley CB, Liu JM [A natural product telomerase activator as part maintenance program: metabolic and cardiovascular response.](https://pubmed.ncbi.nlm.nih.gov/23808324)Rejuvenation Res.(2013-Oct) [^](#ref-link-32)Wang C, Xia Q, Hu B, Jiang W, Zhang H [The Effectiveness and Safety of Huangqi Xixin Decoction for Cough Variant Asthma: A Systematic Review and Meta-Analysis.](https://pubmed.ncbi.nlm.nih.gov/36193126)Evid Based Complement Alternat Med.(2022) [^](#ref-link-33)Su G, Chen X, Liu Z, Yang L, Zhang L, St\u00e5lsby Lundborg C, Wen Z, Guo X, Qin X, Liang J, Liu X [Oral Astragalus (Huang qi) for preventing frequent episodes of acute respiratory tract infection in children.](https://pubmed.ncbi.nlm.nih.gov/27905672)Cochrane Database Syst Rev.(2016-Dec-01) [^](#ref-link-34)Zheng Y, Ren W, Zhang L, Zhang Y, Liu D, Liu Y [A Review of the Pharmacological Action of Astragalus Polysaccharide.](https://pubmed.ncbi.nlm.nih.gov/32265719)Front Pharmacol.(2020) [^](#ref-link-35)Man Li, Elwira Sieniawska, active ingredients of Astragali Radix and its mechanisms in treating cardiovascular and cerebrovascular 8) and molecular mechanisms underlying their potential neuroprotective effects on neurological diseases.](https://pubmed.ncbi.nlm.nih.gov/35780924)Phytochemistry.(2022-Oct) [^](#ref-link-37)Bernardes de Jesus B, Schneeberger K, Vera short telomeres and adult/old mice without increasing cancer incidence.](https://pubmed.ncbi.nlm.nih.gov/21426483)Aging Cell.(2011-Aug) [^](#ref-link-38)Yang Y, Hong M, Lian WW, Chen Z [Review of the pharmacological effects of astragaloside IV and its autophagic mechanism in association with inflammation.](https://pubmed.ncbi.nlm.nih.gov/36246793)World J Clin Cases.(2022-Oct-06) [^](#ref-link-39)Salvador L, Singaravelu Double Blind, and Placebo Controlled Study.](https://pubmed.ncbi.nlm.nih.gov/26950204)Rejuvenation Res.(2016-Dec) [^](#ref-link-40)Molgora B, Bateman R, Sweeney G, Finger D, Effros RB, Valenzuela HF [Functional assessment of pharmacological activators in human T cells.](https://pubmed.ncbi.nlm.nih.gov/24709644)Cells.(2013-Jan-14) - Immunity - Zwickey H, Brush J, Iacullo CM, Connelly E, Gregory pilot study](https://pubmed.ncbi.nlm.nih.gov/17661330)Phytother Res.(2007 Nov) - Diuresis - Ai P, Yong G, Dingkun G, Qiuyu Z, Kaiyuan Z, Shanyan L [Aqueous extract of Astragali Radix induces human natriuresis enhancement of renal response to atrial natriuretic peptide](https://pubmed.ncbi.nlm.nih.gov/18243612)J Ethnopharmacol.(2008 Mar 28) - Korica M, Plavec N [Efficacy and safety of Astragalus membranaceus in the treatment of patients with seasonal allergic rhinitis](https://pubmed.ncbi.nlm.nih.gov/19504468)Phytother Res.(2010 Feb) - Stroke Recovery - Chen CC, Lee HC, Chang JH, Chen SS, Li TC, Cho DY, Hsieh Complement Alternat Ahmed MS, Hou SH, MC, Picken MM, Leehey DJ the herb Astragalus membranaceus](https://pubmed.ncbi.nlm.nih.gov/18037104)Am J Kidney Dis.(2007 Dec) "}